10.1002/chem.202003982
Chemistry - A European Journal
FULL PAPER
2359, 2884, 2947, 3091, 3275 cm-1; 1H-NMR (400 MHz, CD3OD):
3.48-3.59 (2H, m), 3.75, 3.95 (2H, ABq, J = 6.0 Hz), 3.90 (2H,
s), 4.02 (2H, t, J = 4.0 Hz), 4.08 (1H, s), 4.31 (1H, s), 5.10, 5.14
(2H, ABq, J = 12.0 Hz), 5.49 (1H, s), 6.38 (1H, d, J = 8.0 Hz), 6.54
(1H, d, J = 8.0 Hz), 6.79 (1H, t, J = 10.0 Hz), 7.23-7.33 (5H, m),
7.51 (1H, s); 13C-NMR (100.5 MHz, CD3OD): 41.2, 57.6, 67.5,
69.6, 70.2, 72.4, 80.7, 88.7, 90.4, 108.2, 109.3, 116.8, 123.1,
124.9, 128.6, 128.9, 129.4, 129.6, 138.4, 144.3, 147.8, 155.8,
156.2, 159.1; HR-MS (MALDI) calcd. for C26H26N4O9Na [M+Na]+:
561.1592, found: 561.1595.
3275 cm-1; 1H -NMR (400 MHz, CD3CN): 3.39 (2H, s), 3.66, 3.77
(2H, ABq, J = 8.0 Hz), 3.68-3.72 (2H, m) 3.74 (6H, s), 4.03-4.11
(2H, m), 4.18 (1H, d, J = 4.0 Hz), 4.30 (1H, d, J = 4.0 Hz), 4.39
(1H, s), 5.40 (1H, s), 6.21 (1H, dd, J = 8.3, 0.8 Hz), 6.49 (1H, dd,
J = 8.4, 0.7 Hz), 6.75 (1H, t, J = 8.0 Hz), 6.88 (4H, m), 7.23-7.27
(1H, m), 7.31-7.38 (6H, m), 7.47-7.50 (3H, m), 8.00 (1H, s), 8.24
(1H, t, J = 6.0 Hz); 13C-NMR (100.5 MHz, CD3CN): 39.9, 55.9,
59.1, 68.1, 70.4, 72.4, 80.0, 87.2, 87.2, 88.4, 88.6, 88.6, 107.6,
109.1, 114.1, 115.7, 116.4, 123.1, 124.4, 127.9, 128.7, 129.0,
131.0, 136.6, 136.6, 136.6, 143.6, 143.6, 145.8, 146.9, 154.8,
155.0, 158.0, 158.4, 159.7; 19F NMR (376.2 MHz, CD3CN): -
77.2; HR-MS (MALDI) calcd. for C41H37N4O10F3Na [M+Na]+:
825.2354, found: 825.2364.
3-(2′-O,4′-C-methylene-β-D-ribofuranosyl)-9-(2-
aminoethoxy)-1,3-diaza-2-oxophenoxazine (6)
To a solution of 5 (45 mg, 0.084 mmol) in MeOH (10 ml) were
added Pd(OH)2/C (20 mg) and cyclohexene (8 ml), and the
mixture was refluxed for 3 h. After the reaction mixture was cooled
to room temperature, the mixture was filtrated to remove
Pd(OH)2/C. The residue was concentrated under reduced
pressure to give 6 (32 mg, 93%) as a yellow solid; [α]ꢁꢀꢄ -3.7 (c
1.0, DMSO); IR max (KBr): 1009, 1052, 1075, 1094, 1120, 1130,
1202, 1237, 1261, 1282, 1316, 1335, 1368, 1411, 1435, 1475,
1512, 1562, 1608, 1634, 1666, 2343, 2954, 3302 cm-1; 1H-NMR
(500 MHz, DMSO-d6): 2.85-2.88 (2H, m), 3.61, 3.80 (2H, ABq,
J = 6.0Hz), 3.73 (2 H, s), 3.87-3.89 (2/10 H, m), 3.91 (8/10 H, s),
3.92 (2/10 H, s), 4.03-4.06 (8/10 H, m), 4.11 (8/10 H, s), 4.12 (2/10
H, s), 5.32 (8/10 H, s), 5.35 (2/10 H, s), 6.38 (8/10 H, d, J = 4.0
Hz), 6.45 (2/10 H, d, J = 8.0 Hz), 6.56 (8/10 H, d, J = 8.0 Hz), 6.61
(2/10 H, d, J = 8.0 Hz), 6.70 (8/10 H, t, J = 8.0 Hz), 6.80 (2/10 H,
t, J = 6.0 Hz), 7.36 (8/10 H, s), 7.47 (2/10 H, s); 13C-NMR (100.5
MHz, DMSO-d6): 51.1, 55.7, 68.3, 70.9, 73.6, 78.8, 86.6, 88.8,
108.1, 109.3, 117.3, 123.1, 123.2, 126.7, 142.6, 146.9, 152.5,
153.4; HR-MS (MALDI) calcd. for C18H20N4O7Na [M+Na]+:
427.1224, found: 427.1226.
3-(3′-O-β-cyanoethyl-N,N-diisopropylphosphoramidyl-5′-O-
(4,4′-dimethoxytrityl)-2′-O,4′-C-methylene-β-D-
ribofuranosyl)-9-(2-(trifluoroacetylamino)ethoxy)-1,3-diaza-
2-oxophenoxazine (9)
Under argon atmosphere, to a solution of 8 (97 mg, 0.12 mmol) in
CH2Cl2 (2 mL) were added N,N-diisopropylethylamine (DIPEA)
(42
μL,
0.24
mmol)
and
N,N-diisopropylamino-2-
cyanoethylphosphino chloridite (32 L, 0.14 mmol) at 0 °C and
the mixture was stirred for 2 h at room temperature. After addition
of H2O at 0 °C, the mixture was extracted with AcOEt. The organic
extracts were washed with saturated aqueous NaHCO3 solution,
water, and brine, dried over Na2SO4, and then concentrated under
reduced pressure. The residue was purified by silica gel column
chromatography (0.5% triethylamine in n-hexane/AcOEt = 3/7 to
2/8) to give 9 (93 mg, 77%) as a yellow foam; 1H-NMR (400 MHz,
CDCl3): 0.97-1.29 (12H, m), 2.38 (7/8H, t, J = 6.0 Hz), 2.55 (1/8H,
t, J = 6.0 Hz), 3.36 (8/10H, d, J = 12.0 Hz), 3.40 (2/10H, d, J =
12.0 Hz), 3.46-3.57 (5H, m), 3.76-3.82 (10H, m), 4.13-4.17 (2H,
m), 4.25 (2/10H, d, J = 8.0 Hz), 4.33 (8/10H, d, J = 8.0 Hz), 4.60
(17/20H, s), 4.64 (3/20H, s), 5.59 (3/20H, s), 5.61 (17/20H, s),
6.28 (1H, d, J = 8.0 Hz), 6.45 (1H, d, J = 8.0 Hz), 6.79 (1H, t, J =
12.0 Hz), 6.83-6.87 (4H, m), 7.22 (1H, t, J = 8.0 Hz), 7.31 (2H, t,
J = 8.0 Hz), 7.36 (4H, d, J = 8.0 Hz), 7.47 (2H, d, J = 8.0 Hz), 7.54
(1H, s), 8.29 (1H, s), 8.40 (1H, s); 19F-NMR (376.2 MHz, CDCl3):
-76.8, -76.7; 31P-NMR (161.8 MHz, CDCl3): 149.1, 149.4; HR-
MS (MALDI) calcd. for C50H54N6O11F3NaP [M+Na]+: 1025.3433,
found: 1025.3440.
3-(5′-O-(4,4′-dimethoxytrityl)-2′-O,4′-C-methylene-β-D-
ribofuranosyl)-9-{2-(trifluoroacetylamino)ethoxy}-1,3-diaza-
2-oxophenoxazine (8)
Under argon atmosphere, to a solution of 6 (641 mg, 1.56 mmol)
in anhydrous pyridine (60 ml) was added trifluoroaceticacid
anhydride (12 ml, 3.8 mmol) at 0 °C. The mixture was stirred at
room temperature for 2 h. After the reaction mixture was
concentrated to give crude 7 (702 mg). The crude 7 was used for
next step without purification.
Synthesis of ODNs containing BAEO
Synthesis of the ODN containing BAEO was performed on an
Under argon atmosphere, to
a
solution of silver
trifluoromethanesulfonate (AgOTf) (936 mg, 3.64 mmol) in CH2Cl2
(25 mL) was added 4,4′-dimethoxy chloride (DMTrCl) (1.25 g,
3.64 mmol) in CH2Cl2 (5 mL), and the mixture was stirred at room
temperature for 1 h to give DMTrOTf solution. Then, to a solution
of 7 in anhydrous 2,6-lutidine (35 mL) was added DMTrOTf
solution (17 ml) at 0 °C, and the mixture was stirred for 2 h. After
addition of H2O at 0 °C, the mixture was extracted with AcOEt.
The organic layer was washed with saturated aqueous NaHCO3
solution and copper (II) sulfate aqueous solution (3.0 g in 20 ml
H2O) to remove 2,6-lutidine, and dried over Na2SO4, and then
concentrated under reduced pressure. The residue was purified
by silica gel column chromatography (0.5% triethylamine in n-
hexane/AcOEt = 2/8 to 0/1) to give 8 (597 mg, 47% in 2 steps) as
a yellow foam; [α]ꢀꢁꢂ -8.1 (c 1.0, CH3CN); IR max (KBr): 1017,
1057, 1081, 1104, 1155, 1190, 1228, 1261, 1287, 1329, 1363,
1383, 1418, 1446, 1480, 1517, 1566, 1612, 1676, 1726, 1969,
2048, 2177, 2300, 2359, 2428, 2548, 2601, 2837, 2949, 3091,
automated DNA synthesizer (Gene Design, nS-8) at 0.2 mole
scale.
Then,
5-[3,5-bis(trifluoromethyl)phenyl]-1H-tetrazole
(Activator 42®) was used as the activator. The coupling time of
standard phosphoramidite coupling protocol was increased from
30 s to 12 min. The BAEO phosphoramidite 9 was prepared with
0.10 M acetonitrile/tetrahydrofuran (v/v, 3:1). The oligonucleotide
synthesis was performed on the DMTr-on mode. Controlled Pore
Glass (CPG)-supported ODNs were cleaved and their protected
groups of nucleobases were removed with 50 mM K2CO3 in
MeOH solution at rt for 4 h. The DMTr group in ODNs were
detritylated and purified with a Sep-Pak® Plus C18 Cartridge and
Sep-Pak® Plus C18 Environmental Cartridge (Waters) [washed
with 10% acetonitrile aqueous solution, detritylated with 0.5%
aqueous trifluoro acetic acid solution, and eluted with 35%
aqueous MeOH solution]. ODNs were purified by reverse-phase
HPLC on a Waters XBridgeTM OST C18 2.5 m (10 × 50 mm)
using 0.1 M triethylammonium acetate (TEAA) buffer (pH: 7.0)
This article is protected by copyright. All rights reserved.